|
|
|
| Developing new delivery routes for biological therapies is essential for creating more patient-centric and effective treatments. By using nanoforming techniques, it's possible to simplify dosing regimens and enhance patient comfort, compliance, and even reduce overall healthcare costs. Find out how this is best demonstrated through two real-world examples. Learn more |
|
|
|
| The Next Leap In Pharma Manufacturing | White Paper | Blue Mountain | Explore how Industry 4.0 integration transforms pharma manufacturing through connected systems, data-driven insights, and predictive, compliant operations. |
|
|
|
|
|
|
By Katie Anderson, Chief Editor, Pharmaceutical Online | Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| The Impact Of The FDA's New CSA Draft Guideline | Article | By Nelly Chankova, Koerber Pharma | Ensure product quality and patient safety by examining the FDA's draft guideline on Computer Software Assurance that emphasizes a risk-based approach to streamline software validation. |
|
|
|
| Five Tests For Pharmaceutical Containment | Article | Flow Sciences Inc. | As APIs increase in potency and become more hazardous, delve into different containment methods and determine which would be most beneficial for your first (or next) containment device. |
|
|
|
|
| A Novel Patient-Derived Colorectal Cancer Organoid Platform | Application Note | By Angeline Lim, Jason Baade, Aditya Katiyar, et al., Danaher Life Sciences | Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting efficacy. Gain insight into a scalable bioprocess that enhances reproducibility and cost-effectiveness. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|